Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7.

Zhang J, Gong WH, Li Y, Zhang HY, Zhang CX

Open source

DOI
10.26355/eurrev_201908_18540
Published
2019 Aug
Container
European review for medical and pharmacological sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_201908_18540,
  title = {Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7.},
  author = {Zhang J and Gong WH and Li Y and Zhang HY and Zhang CX},
  year = {2019},
  journal = {European review for medical and pharmacological sciences},
  doi = {10.26355/eurrev_201908_18540},
  url = {https://doi.org/10.26355/eurrev_201908_18540}
}

RIS

TY  - JOUR
TI  - Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7.
AU  - Zhang J
AU  - Gong WH
AU  - Li Y
AU  - Zhang HY
AU  - Zhang CX
PY  - 2019
JO  - European review for medical and pharmacological sciences
DO  - 10.26355/eurrev_201908_18540
UR  - https://doi.org/10.26355/eurrev_201908_18540
ER  - 

APA

J, Z., WH, G., Y, L., HY, Z., & CX, Z. (2019). Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201908_18540

Source records